ARTICLE | Financial News
EpimAb completes venture financing
April 27, 2017 9:10 PM UTC
On April 25, bi-specific antibody company EpimAb Biotherapeutics Inc. (Shanghai, China) raised $25 million in a series A round led by Oriza Seed Capital. Also participating were Decheng Capital, 3E B...
BCIQ Company Profiles